Skip to main content

Table 2 The patient presurgery characteristics in PPV and SB group

From: The impact of the COVID-19 Pandemic on rhegmatogenous retinal detachment treatment patterns

 

PPV (162)

SB (96)

P

group (COVID/pre-COVID)

57/105

22/74

0.054

gender (male/female)

100/62

60/36

1

age (mean±SD, y)

52.7 + 13.6

39.9 + 19.9

< 0.001

presurgery waiting time (median, d)

4 [2,8]

4 [3,12]

0.51

RRD-CD (n)

55

17

< 0.001

dense VH (n)

7

3

0.74

recurrent RRD (n)

19

4

0.04

VA less than 0.02 (n)

99

24

< 0.001

VA 0.02-0.1 (n)

45

31

0.48

VA 0.1-0.5 (n)

13

30

< 0.001

VA greater than 0.5 (n)

5

11

0.01

PM (n)

57

23

0.08

pseudophakia (n)

35

7

0.004

retinal breaks location (n)

   

anterior

69

82

< 0.001

posterior

67

12

< 0.001

macular hole (n)

2

26

0.0003

macular-off (n)

15

33

< 0.001

PVR B-C (n)

128

96

< 0.001